18 February 2023>: Clinical Research
Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibodies to Infliximab in 32 Patients with Moderate to Severe Inflammatory Bowel Disease
Tomislav Jukic 1CDEF , David Drobne 2ABCDE , Sasa Pusavec 3BF , Alojz Ihan 3AE , David Stubljar 4ACDE* , Andrej Starc 5DEDOI: 10.12659/MSM.939084
Med Sci Monit 2023; 29:e939084
Table 6 Number of samples with detectable (+) and undetectable (−) antibodies to IFX for a respective test.
ATI Lisa-Tracker + | ATI Lisa-Tracker − | |
---|---|---|
ATI UHL + | 9 | 0 |
ATI UHL − | 3 | 2 |